Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/25/22 19:37 | 8/25/22 | AGLE | Health | Drug | Pharmaceutical Preparations | Souza Marcio | TX | D | P | 50 | 0.5608 | 0 | 90 | New | 90 | D | |||||||||||||||
6/10/22 18:24 | 6/8/22 | AGLE | Health | Drug | Pharmaceutical Preparations | Hanley Jr. Michael Conick | TX | O | Chief Co | P | 20 | 0.7100 | 0 | 28 | 353 | 36 | D | ||||||||||||||
3/18/22 06:46 | 3/16/22 | AGLE | Health | Drug | Pharmaceutical Preparations | Quinn Anthony G. | TX | DO | P,CEO | P | 188 | 2.34 | 0 | 80 | 11 | 817 | D | ||||||||||||||
3/15/22 18:32 | 3/11/22 | AGLE | Health | Drug | Pharmaceutical Preparations | Quinn Anthony G. | TX | DO | P,CEO | P.m | 281 | 1.94 | 0 | 145 | 24 | 740 | D | ||||||||||||||
3/15/22 18:30 | 3/11/22 | AGLE | Health | Drug | Pharmaceutical Preparations | Alspaugh Jonathan | TX | O | CFO | P | 156 | 2.08 | 0 | 75 | 83 | 165 | D | ||||||||||||||
12/13/21 20:41 | 12/9/21 | AGLE | Health | Drug | Pharmaceutical Preparations | Shanafelt Armen | TX | D | P.m | 550 | 3.66 | 0 | 150 | New | 150 | D | |||||||||||||||
12/13/21 20:39 | 12/9/21 | AGLE | Health | Drug | Pharmaceutical Preparations | Quinn Anthony G. | TX | DO | P,CEO | P.m | 199 | 3.71 | 0 | 54 | 10 | 595 | D | ||||||||||||||
12/13/21 20:37 | 12/9/21 | AGLE | Health | Drug | Pharmaceutical Preparations | Alspaugh Jonathan | TX | O | CFO | P | 186 | 3.72 | 0 | 50 | 124 | 90 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |